EX-99.77K CHNG ACCNT

October 23, 2007

Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549

Commissioners:

We have read the statements made by
Eaton Vance Global Growth Portfolio
(copy attached), which we understand will
be filed with the Securities and Exchange
Commission, pursuant to Item 77K of
Form N-SAR, as part of the Form N-SAR
of Eaton Vance Global Growth Portfolio to
be dated October 29, 2007.  We agree with
the statements concerning our Firm in such
Form N-SAR.

Very truly yours,



PricewaterhouseCoopers LLP
















Eaton Vance Management


The Eaton Vance Building
255 State Street, Boston, MA 02109
(617) 482-8260



October 15, 2007

PricewaterhouseCoopers LLP
125 High Street
Boston, Massachusetts 02110

Dear Sirs:

In accordance with the requirements of item
304 of Regulation S-K, please provide us
with a letter(s) from your firm addressed to
the Securities and Exchange Commission
stating your agreement with the statements
made in the enclosed attachment with
respect to certain Eaton Vance Funds and
Portfolios as referred to therein.

A copy of your letter will be filed with the
Securities and Exchange Commission, along
with the statement as attached, as an exhibit
to the respective Fund's or Portfolio's next
Form N-SAR for the period ended August
31, 2007 (in accordance with Item 77K of
Form N-SAR).

Sincerely,



Barbara E. Campbell
Vice President, Eaton Vance Management




Applicable to Eaton Vance Global Growth
Fund and Portfolio, Eaton Vance Multi-Cap
Growth Fund and Portfolio, and Eaton
Vance Worldwide Health Sciences Fund and
Portfolio:

OTTHER MATTERS

Change in Independent Registered Public
Accounting Firm

On August 6, 2007,
PricewaterhouseCoopers LLP resigned in
the ordinary course as the independent
registered public accounting firm for the
Fund and Portfolio effective upon
completion of services related to the audit
for the Fund's and Portfolio's 2007 fiscal
year.

The reports of PricewaterhouseCoopers LLP
on the Fund's and Portfolio's financial
statements for each of the last two fiscal
years contained no adverse opinion or
disclaimer of opinion and were not qualified
or modified as to uncertainty, audit scope or
accounting principle.  There have been no
disagreements with PricewaterhouseCoopers
LLP during the Fund's and Portfolio's two
most recent fiscal years and any subsequent
interim period on any matter of accounting
principles or practices, financial statement
disclosure or auditing scope or procedure,
which disagreements if not resolved to the
satisfaction of PricewaterhouseCoopers
LLP, would have caused them to make
reference thereto in their reports on the
Fund's and Portfolio's financial statements
for such years, and there were no reportable
events of the kind described in Item 304
(a)(1)(v) of Regulation S-K under the
Securities Exchange Act of 1934, as
amended.

At a meeting held on August 6, 2007, based
on Audit Committee recommendations and
approvals, the full Board of Trustees of the
Fund and Portfolio approved Deloitte &
Touche LLP as the Fund's and Portfolio's
independent registered public accounting
firm for the fiscal year ending August 31,
2008.  To the best of the Fund's and
Portfolio's knowledge, for the fiscal years
ended August 31, 2007 and August 31,
2006, and through October 15, 2007, the
Fund and Portfolio did not consult with
Deloitte & Touche LLP on items which
concerned the application of accounting
principles to a specified transaction, either
completed or proposed, or the type of audit
opinion that might be rendered on the
Fund's and Portfolio's financial statements
or concerned the subject of a disagreement
(as defined in paragraph (a)(1)(iv) of Item
304 of Regulation S-K) or reportable events
(as described in paragraph (a)(1)(v) of Item
304 of Regulation S-K).

EX-99.77B ACCT LTTR

Report of Independent Registered Public
Accounting Firm

To the Shareholders and Trustees
of Eaton Vance Global Growth Portfolio


In planning and performing our audit of the
financial statements of Eaton Vance Global
Growth Portfolio ("the Portfolio") as of and
for the year ended August 31, 2007, in
accordance with the standards of the Public
Company Accounting Oversight Board
(United States), we considered the
Portfolio's internal control over financial
reporting, including control activities for
safeguarding securities, as a basis for
designing our auditing procedures for the
purpose of expressing our opinion on the
financial statements and to comply with the
requirements of Form N-SAR, but not for
the purpose of expressing an opinion on the
effectiveness of the Portfolio's internal
control over financial reporting.
Accordingly, we do not express an opinion
on the effectiveness of the Portfolio's
internal control over financial reporting.

The management of the Portfolio is
responsible for establishing and maintaining
effective internal control over financial
reporting.  In fulfilling this responsibility,
estimates and judgments by management are
required to assess the expected benefits and
related costs of controls.  A company's
internal control over financial reporting is a
process designed to provide reasonable
assurance regarding the reliability of
financial reporting and the preparation of
financial statements for external purposes in
accordance with generally accepted
accounting principles.  Such internal control
over financial reporting includes policies
and procedures that provide reasonable
assurance regarding prevention or timely
detection of unauthorized acquisition, use or
disposition of a company's assets that could
have a material effect on the financial
statements.

Because of its inherent limitations, internal
control over financial reporting may not
prevent or detect misstatements.  Also,
projections of any evaluation of
effectiveness to future periods are subject to
the risk that controls may become
inadequate because of changes in conditions,
or that the degree of compliance with the
policies or procedures may deteriorate.

A control deficiency exists when the design
or operation of a control does not allow
management or employees, in the normal
course of performing their assigned
functions, to prevent or detect misstatements
on a timely basis. A significant deficiency is
a control deficiency, or combination of
control deficiencies, that adversely affects
the company's ability to initiate, authorize,
record, process or report external financial
data reliably in accordance with generally
accepted accounting principles such that
there is more than a remote likelihood that a
misstatement of the company's annual or
interim financial statements that is more
than inconsequential will not be prevented
or detected.  A material weakness is a
control deficiency, or combination of control
deficiencies, that results in more than a
remote likelihood that a material
misstatement of the annual or interim
financial statements will not be prevented or
detected.

Our consideration of the Portfolio's internal
control over financial reporting was for the
limited purpose described in the first
paragraph and would not necessarily
disclose all deficiencies in internal control
over financial reporting that might be
significant deficiencies or material
weaknesses under standards established by
the Public Company Accounting Oversight
Board (United States).  However, we noted
no deficiencies in the Portfolio's internal
control over financial reporting and its
operation, including controls for
safeguarding securities, that we consider to
be material weaknesses as defined above as
of August 31, 2007.

This report is intended solely for the
information and use of management and the
Trustees of Eaton Vance Global Growth
Portfolio and the Securities and Exchange
Commission and is not intended to be and
should not be used by anyone other than
these specified parties.





October 15, 2007





		(3)

PricewaterhouseCoopers LLP
125 High Street
Boston, MA 02110-1707
Telephone (617) 530 5000
Facsimile (617) 530 5001
www.pwc.com